TABLE 2.
Institution | Type and year of publication | Target population(s) | Summary of recommendations regarding LCSs |
---|---|---|---|
WHO | Guideline, 2023 [9] | General population |
|
American Heart Association | Advisory paper, 2018 [47] | General population and patients with diabetes |
|
Diabetes UK | Position statement, 2018 [45] | Patients with diabetes |
|
American Diabetes Association | Information on website, 2024 [46] | Patients with diabetes |
|
Abbreviation: LCS, low-calorie sweetener.